8,517 articles
Christopher Dye
Christopher Dye is a British epidemiologist who worked on tuberculosis and HIV/AIDS at the World Health Organization for 22 years, then became Professor of Epidemiology at Oxford in 2018.
Christopher E. Brightling
Christopher E. Brightling, born 1968, is a British Clinical Professor of Respiratory Medicine at the University of Leicester known for asthma research and leading the national PHOSP-COVID study.
Christopher E. Henderson
Christopher E. Henderson is a Cambridge-trained neuroscientist who established GDNF as a motor neuron survival factor and built early human stem cell models of ALS.
Christopher E. Mason
Christopher E. Mason, also known as Christopher Mason, is a geneticist and computational biomedicine researcher at Weill Cornell Medicine, known for epitranscriptomics and space-omics work.
Christopher Heeschen
Christopher Heeschen is a German physician-scientist known for the first identification of pancreatic cancer stem cells, now a professor at Shanghai Jiao Tong University School of Medicine and director of a pancreatic cancer laboratory in Italy.
Christopher Hourigan
Christopher Simon Hourigan (DM, DPhil, FRCP) is an oncologist and physician-scientist known for founding AML measurable residual disease (MRD) testing, the 2019 JCO phase 3 trial, Pre-MEASURE, and MEASURE (NCT05224661); formerly NHLBI tenured investigator, now Virginia Tech Fralin Cancer Research Center director.
Christopher J. Bulpitt
Christopher J. Bulpitt is a physician-epidemiologist and Emeritus Professor of Geriatric Medicine at Imperial College London, chief investigator of the HYVET trial of treating hypertension in people aged 80 and over.
Christopher J. Hawkey
Christopher J. Hawkey, also known as C J Hawkey, is a British gastroenterologist at the University of Nottingham whose trials established proton pump inhibitor prophylaxis against ulcers caused by NSAIDs and aspirin.
Christopher J. O’Donnell
Christopher J. O'Donnell is an American cardiologist and physician-scientist who led cardiovascular genomics research at the Framingham Heart Study and NHLBI, then joined Novartis in 2021.
Christopher J. Sweeney
Christopher J. Sweeney is an Australian-trained medical oncologist and inaugural Director of the South Australian immunoGENomics Cancer Institute, known for leading the CHAARTED and ENZAMET trials.
Christopher J.L. Murray
Christopher J.L. Murray is a physician and epidemiologist who co-created the Global Burden of Disease study and the DALY metric, and founded the Institute for Health Metrics and Evaluation in 2007.
Christopher K. Glass
Christopher K. Glass is an American physician-scientist, Distinguished Professor of Cellular and Molecular Medicine at UC San Diego since 1989, known for discovering transcriptional mechanisms regulating macrophage inflammation in atherosclerosis, diabetes, and neurodegeneration.
Christopher M. Booth
Christopher M. Booth is a Canadian medical oncologist and clinician-scientist at Queen's University in Kingston, Ontario, who led the CHALLENGE trial of exercise after colon cancer chemotherapy.
Christopher M. O’Connor
Christopher M. O'Connor is an American cardiologist and clinical trialist who has led the Inova Heart and Vascular Institute since 2015 after a long career at Duke University.
Christopher M. Walker
Christopher M. Walker is an American viral immunologist at Nationwide Children's Hospital in Columbus, Ohio, known for work on T-cell immunity to hepatitis C and hepatitis E viruses.
Christopher Newton‐Cheh
Christopher Newton-Cheh is an American heart failure cardiologist and cardiovascular geneticist at Massachusetts General Hospital and Harvard Medical School, known for large-scale genetic studies of blood pressure.
Christopher P. Cannon
Christopher P. Cannon is an American cardiologist, professor of medicine at Harvard Medical School and senior physician at Brigham and Women's Hospital, who led more than 20 clinical trials.
Christopher P. Day
Christopher P. Day is a British hepatologist who has been Vice-Chancellor of Newcastle University since 2017 and created the NAFLD Fibrosis Score and the two-hit model of steatohepatitis.
Christopher P. Landrigan
Christopher P. Landrigan is an American pediatrician and patient-safety researcher, Chief of General Pediatrics at Boston Children's Hospital, whose work on resident sleep and the I-PASS handoff program reduced medical errors.
Christopher S. Wilcox
Christopher S. Wilcox is a British-born physician-scientist in renal physiology and hypertension who led Georgetown University's nephrology division and researched oxidative stress as a cause of hypertension.
Christopher Semsarian
Christopher Semsarian AM is an Australian cardiologist and Professor of Medicine at the University of Sydney known for research into the genetic causes of sudden cardiac death in young people.
Christopher V. Plowe
Christopher V. Plowe is an American physician-scientist who studies drug-resistant malaria, directs the Duke Global Health Institute since 2018, and validated the molecular marker for chloroquine resistance.
Christopher Vakoc
Christopher R. Vakoc is an American cancer biologist at Cold Spring Harbor Laboratory who studies epigenetic regulation in leukemia and pancreatic cancer, known for identifying BRD4 as a leukemia drug target.
Christopher W.G. Redman
Christopher W.G. Redman (1941–2024) was a British obstetrician at Oxford who pioneered research on pre-eclampsia, held the world's first Chair of Obstetric Medicine, and created the Dawes-Redman fetal heart rate system used in over 130 countries.
Christos A. Athanasoulis
Christos A. Athanasoulis is a vascular and interventional radiologist at Massachusetts General Hospital and Harvard Medical School whose 1974 and 1980 New England Journal of Medicine papers established therapeutic angiography.
Christos Davatzikos
Christos Davatzikos (Χρήστος Δαβατζίκος) is a Greek researcher in biomedical image analysis and machine learning for radiology, the Wallace T. Miller Sr. Professor of Radiology at the University of Pennsylvania.
Christos S. Mantzoros
Christos S. Mantzoros is a physician-scientist in endocrinology and metabolism at Harvard Medical School and Beth Israel Deaconess Medical Center, known for his research on the hormone leptin.
Chrysostomos P. Panayiotopoulos
Chrysostomos P. Panayiotopoulos, known as Tomis, was a Greek-born neurologist at St Thomas' Hospital in London who described Panayiotopoulos syndrome, a benign childhood autonomic epilepsy.
Chung Owyang
Chung Owyang is an American gastroenterologist at the University of Michigan Medical School, known for identifying the CCK-releasing peptide and awarded the AGA's 2022 William Beaumont Prize.
Chunliang Li
Chunliang Li is a Chinese-born cancer and genome-biology researcher who has been an Associate Member in Tumor Cell Biology at St. Jude Children's Research Hospital since 2023.